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INVITED COMMENTARY
Richard P. Cambria, MD, Boston, Mass
In the 20 years since we described the importance of malper-
fusion syndrome (MPS) to outcomes in aortic dissection,1 consid-
erable progress in understanding its pathogenesis, as described by
Williams et al,2 and treatment have occurred. There is consensus
that MPS complicates aortic dissection in a third of patients and, in
addition to aortic rupture, is a principle cause of death, in particular
when carotid/mesenteric and renal arteries are affected. This con-
sensus dissipates because the heterogeneity of pathologic anatomy
(static vs dynamic mechanisms, type A or B lesion, acute or chronic
circumstance), clinical presentations, and therapeutic capabilities
of treating surgeons/interventionalists greatly influence both clin-
ical decision making and results of treatment.
Numerous important clinical data are either first described or
re-emphasized by this prodigious experience from the Michigan
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group. These include the discrepant pathologic anatomy of right vs
left renal artery, a perhaps higher than anticipated incidence of
static obstruction (ie, the dissecting process proceeds into the
branch vessel itself), the fact that persistent MPS either in the
chronic phase of the disease or after surgical central aortic repair
does occur, and the “yield” of renal MPS when suspected by
clinical or radiographic findings.
Two points are worthy of emphasis with respect to the latter:
(1) the authors use aortic root-to-branch pressure gradients as the
gold standard of definingMPS, and (2) there is little consideration
(ie, not in their data set) of the great importance of axial imaging,
such as by computed tomography (CT) scans, in both the suspi-
cion for, and diagnosis of, MPS. Indeed, in our practice—and I
strongly suspect this is generally true—it is the anatomy derived
from three-dimensional CT scanning that both directs clinical
decision making and forms the fundamental and critical initial step
of understanding the pathologic anatomy.
Any intervention, be it open surgical, endovascular, thoracic
endovascular aneurysm repair (TEVAR), or a combination of
these, is predicated on such understanding, which also forms the
basis of the intraprocedural intravascular ultrasound (IVUS) inter-
rogation. I certainly agree with the authors that IVUS is an
essential component of any endovascular procedure for aortic
dissection; thus, catheter-based angiography is rarely used in a
strictly diagnostic mode in aortic dissection patients. Rather, it may
be a component of a comprehensive endovascular approach to
MPS.
Although the authors emphasize the efficacy of their ap-
proach, the mortality at 21% is substantial. This rarely represents
technical failure or complication of the endovascular therapy, but
rather, the additive effects of other affected vascular beds (partic-
ularly mesenteric ischemia) and delays in diagnosis and treatment
of MPS. Perhaps not appropriately emphasized in their report is
that TEVAR technology can and will change the treatment of
MPS, at least in patients with type B aortic dissection. The ability to
seal an aortic entry tear, redirect flow into the aortic true lumen,
and thereby relieve MPS—at least wherein dynamic obstruction is
the mechanism—has been an important advance in type B aortic
dissection. Certainly, aortic branch orificial stenting may also be
required, especially in static obstruction. Clinical trials of dissec-
tion-specific TEVAR devices for complicated type B cases have
begun.
Finally, such TEVAR approaches have a distinct potential
advantage compared with the techniques described in this report. I
refer, of course, to the anticipated aortic remodeling that likely will
occur after TEVAR obliteration of the proximal entry tear, thereby
obviating chronic aneurysmal dilatation of the outer wall of the
false lumen and the need for late aortic replacement, which cur-
rently affects at least 40% of acute dissection patients irrespective of
initial treatment. This is a timely and important contribution as
management of MPS evolves in the TEVAR era.
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